HCPCS Level II code G0435 designates a rapid antibody screening test for HIV-1 and/or HIV-2. This code captures point-of-care, rapid infectious agent antibody detection used for screening individuals for HIV infection. Rapid HIV screening is a critical public health tool because it enables timely identification of cases, immediate counseling or linkage to confirmatory testing, and quicker initiation of care pathways when needed.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what G0435 represents clinically and operationally, coverage considerations across major national payers, and the typical sites where this service is delivered. The publication outlines common billing contexts, payer policy themes, and coding considerations relevant to ambulatory and point-of-care settings.

The report provides benchmarks and policy summaries to help billing managers and compliance staff understand reimbursement positioning for rapid HIV screening, highlights payer coverage patterns, and summarizes clinical context for appropriate use. Data not available in the input for specific modifiers, taxonomies, ICD-10 pairings, and related codes is noted where applicable.